DV
DVL.AU Dorsavi Ltd
- Market cap
- AUD 28.8M
- P/E
- -
- P/B
- 6.64x
- ROE
- -196.6%
- Dividend yield
- -
- Fundamental score
- 1.1/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is DVL.AU undervalued?
Graham numberThe Graham number of Dorsavi Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Dorsavi Ltd fundamental analysis
5 of 21 checks passedROE 0/2
Low return on equity (-196.6%), below 10%.
ROA 0/1
Return on assets (-145.8%) is below the industry median (-51.4%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-251.5%) is below the industry median (-5.3%).
Revenue Growth 0/2
Revenue shrank 16.9% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (1.6%), 40% or less.
Debt Trend 1/1
Debt to equity has not risen over the past 5 years.
Cash Runway 0/2
Cash covers 0.4 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book (6.6x) is above the industry median (4.4x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Dorsavi Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Dorsavi Ltd
dorsaVi Ltd develops and sells motion analysis technologies in Australia, Europe, and the United States. It operates through three segments: Clinical, Workplace, and RRAM. The company provides ViMove+, a clinical and sports solutions; VideoAI, a visual movement data; ViSafe+, a measure movement, identify risk, and support proactive safety programs; and Research+, a precision tools for movement research. It serves clinic and sports, workplace, and research industries. dorsaVi…
Full company profileDorsavi Ltd financial statements
Dorsavi Ltd annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 3.47M | 3.43M | 2.51M | 2.02M | 1.87M | 2.35M | 1.75M | 1.30M | 1.13M | 1.00M |
| Gross Profit | 2.22M | 2.56M | 2.07M | -2.21M | -1.74M | -1.45M | -798K | 1.18M | 972K | -3.33M |
| Operating Income | -4.80M | -5.14M | -5.12M | -3.96M | -3.08M | -2.83M | -2.37M | -1.69M | -1.88M | -7.48M |
| EBITDA | -4.54M | -4.75M | -3.59M | -6.84M | -2.29M | -1.53M | -1.88M | -1.60M | -1.82M | -7.36M |
| Net Income | -3.88M | -3.73M | -4.02M | -7.59M | -2.41M | -1.54M | -1.82M | -1.25M | -1.52M | -8.52M |
| EPS | -0.02 | -0.02 | -0.02 | -0.03 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Balance Sheet | ||||||||||
| Total Assets | 14.5M | 10.9M | 9.23M | 3.83M | 5.42M | 3.36M | 2.69M | 2.18M | 3.97M | 5.85M |
| Total Liabilities | 1.35M | 1.51M | 2.24M | 3.37M | 2.95M | 2.13M | 1.01M | 1.16M | 1.14M | 1.51M |
| Shareholders' Equity | 13.1M | 9.42M | 6.99M | 459K | 2.48M | 1.22M | 1.68M | 1.02M | 2.84M | 4.34M |
| Cash & Short-term Investments | 8.61M | 3.97M | 2.77M | 1.69M | 2.80M | 450K | 879K | 478K | 2.29M | 2.12M |
| Total Debt | 1.00K | - | 361K | 1.91M | 1.42M | 1.18M | 322K | 190K | 157K | 68.3K |
| Cash Flow | ||||||||||
| Operating Cash Flow | -3.39M | -2.60M | -2.08M | -2.18M | -2.27M | -2.15M | -967K | -601K | -957K | -5.28M |
| Capital Expenditure | 133K | 50.0K | 34.0K | 789K | 85.4K | 100K | 51.7K | 21.2K | 3.00 | 5.64K |
| Free Cash Flow | -3.52M | -2.65M | -2.12M | -2.97M | -2.36M | -2.25M | -1.02M | -622K | -957K | -5.28M |
| Ratios | ||||||||||
| ROE | -29.5% | -39.6% | -57.5% | -1,654.2% | -97.4% | -125.8% | -108.5% | -121.9% | -53.5% | -196.6% |
| ROA | -26.8% | -34.1% | -43.6% | -198.4% | -44.5% | -45.8% | -67.7% | -57.1% | -38.2% | -145.8% |
| Net Profit Margin | -111.8% | -108.6% | -159.9% | -376.0% | -129.1% | -65.3% | -104.0% | -95.7% | -134.4% | -849.2% |
| Debt to Equity | 0.00x | - | 0.05x | 4.17x | 0.57x | 0.97x | 0.19x | 0.19x | 0.06x | 0.02x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Dorsavi Ltd dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | AUD 1.38M | 0.00 | - |
| 2022 | AUD 1.33M | 0.00 | - |
| 2021 | AUD 3.36M | 0.01 | - |
| 2020 | AUD 1.78M | 0.01 | - |
| 2019 | AUD 35.0K | 0.00 | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 65:64 on Aug 2, 2022.
Who owns Dorsavi Ltd
- Insiders 44.61%
- Institutions 7.11%
- Public & others 48.28%
- Shares outstanding 1.37B
- Free float 614M
Dorsavi Ltd company profile
- Company name
- Dorsavi Ltd
- Ticker
- DVL.AU
- ISIN
- AU000000DVL0
- Exchange
- Australian Securities Exchange
- Sector
- Technology
- Industry
- Biotechnology
- Fiscal year end
- June
- Address
- 11-13 Milgate Street, Oakleigh South, VIC, Australia, 3167
- Phone
- 61 3 1800 367 728
- Website
- dorsavi.com
About Dorsavi Ltd
dorsaVi Ltd develops and sells motion analysis technologies in Australia, Europe, and the United States. It operates through three segments: Clinical, Workplace, and RRAM. The company provides ViMove+, a clinical and sports solutions; VideoAI, a visual movement data; ViSafe+, a measure movement, identify risk, and support proactive safety programs; and Research+, a precision tools for movement research. It serves clinic and sports, workplace, and research industries. dorsaVi Ltd was incorporated in 2008 and is based in Oakleigh South, Australia.
Dorsavi Ltd management
7- Mr. Gernot Kurt Abl B.Com., L.L.B.Executive Chairman
- Mr. Mathew ReganGroup Chief Executive Officer
- Dr. Andrew James Ronchi B.App.Sci., GAICD, Ph.D.Co-Founder & CEO of Sensor Division
- Mr. Aaron ChanChief Financial Officer · born 1977
- Ms. Mary StewartAccount Manager & Head of Clinical Sales
- Mr. Daniel Mathew Ronchi Ass.Deg.LawChief Technology Officer
- Mr. Justin Mouchacca B.Bus (Acc), C.A.Company Secretary